Literature DB >> 14570718

Aspirin: still learning about the wonder drug.

E T Hawk1, J L Viner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14570718      PMCID： PMC1773852          DOI： 10.1136/gut.52.11.1535

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  15 in total

Review 1.  Biomarkers as surrogates for cancer development.

Authors:  E Hawk; J L Viner; J A Lawrence
Journal:  Curr Oncol Rep       Date:  2000-05       Impact factor: 5.075

2.  Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression.

Authors:  M J Wargovich; A Jimenez; K McKee; V E Steele; M Velasco; J Woods; R Price; K Gray; G J Kelloff
Journal:  Carcinogenesis       Date:  2000-06       Impact factor: 4.944

Review 3.  Epidemiology and prevention of colorectal cancer.

Authors:  Ernest T Hawk; Paul J Limburg; Jaye L Viner
Journal:  Surg Clin North Am       Date:  2002-10       Impact factor: 2.741

4.  A randomized trial of aspirin to prevent colorectal adenomas.

Authors:  John A Baron; Bernard F Cole; Robert S Sandler; Robert W Haile; Dennis Ahnen; Robert Bresalier; Gail McKeown-Eyssen; Robert W Summers; Richard Rothstein; Carol A Burke; Dale C Snover; Timothy R Church; John I Allen; Michael Beach; Gerald J Beck; John H Bond; Tim Byers; E Robert Greenberg; Jack S Mandel; Norman Marcon; Leila A Mott; Loretta Pearson; Fred Saibil; Rosalind U van Stolk
Journal:  N Engl J Med       Date:  2003-03-06       Impact factor: 91.245

5.  Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac.

Authors:  B Agarwal; C V Rao; S Bhendwal; W R Ramey; H Shirin; B S Reddy; P R Holt
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

6.  A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

Authors:  Robert S Sandler; Susan Halabi; John A Baron; Susan Budinger; Electra Paskett; Roger Keresztes; Nicholas Petrelli; J Marc Pipas; Daniel D Karp; Charles L Loprinzi; Gideon Steinbach; Richard Schilsky
Journal:  N Engl J Med       Date:  2003-03-06       Impact factor: 91.245

Review 7.  The future of colon cancer prevention.

Authors:  A Umar; J L Viner; E T Hawk
Journal:  Ann N Y Acad Sci       Date:  2001-12       Impact factor: 5.691

8.  Early cellular events in colorectal carcinogenesis.

Authors:  A. G Renehan; S. T O'Dwyer; N. J Haboubi; C. S Potten
Journal:  Colorectal Dis       Date:  2002-03       Impact factor: 3.788

9.  Suppressive effect of aspirin on aberrant crypt foci in patients with colorectal cancer.

Authors:  B Shpitz; E Klein; G Buklan; D Neufeld; A Nissan; H R Freund; M Grankin; J Bernheim
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

10.  Dietary conjugated linolenic acid inhibits azoxymethane-induced colonic aberrant crypt foci in rats.

Authors:  Hiroyuki Kohno; Rikako Suzuki; Ryoko Noguchi; Masashi Hosokawa; Kazuo Miyashita; Takuji Tanaka
Journal:  Jpn J Cancer Res       Date:  2002-02
View more
  1 in total

1.  Developing Faith-Based Health Promotion Programs that Target Cardiovascular Disease and Cancer Risk Factors.

Authors:  Clare Burchenal; Shanna Tucker; Orysya Soroka; Francesse Antoine; Rosio Ramos; Holly Anderson; Naa-Solo Tettey; Erica Phillips
Journal:  J Relig Health       Date:  2021-12-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.